Stem Cells International

The Development of Biomaterials and Stem Cells for Musculoskeletal Disorders


Publishing date
01 May 2022
Status
Published
Submission deadline
07 Jan 2022

1Sri Ramachandra Institute of Higher Education and Research, Chennai, India

2Universiti Malaya, Kuala Lumpur, Malaysia

3Universiti Malaya, Kuala Lumpur, Malaysia


The Development of Biomaterials and Stem Cells for Musculoskeletal Disorders

Description

Musculoskeletal (MSK) disorders are the second most common cause of disability worldwide, impacting more than 1.7 billion people. Among many conditions related to MSK, osteoarthritis is a degenerative disorder that does not currently have a permanent cure. Scientists around the globe are facing many challenges in developing appropriate treatments for the regeneration of damaged cartilage.

Though research on biomaterials and stem cells has been progressing well, in order to find a permanent solution, there are many concerns that remain elusive. These challenges include the inconsistency in therapy outcomes due to dedifferentiation of stem cells, immunological-related concerns, lack of biomechanical properties, etc. As such, the development of suitable combination regenerative therapies using stem cells and biomaterials is still being actively researched. Exploring the challenges and advancements in the development of superior stem cell extracellular biomimetic cues for musculoskeletal disorders would certainly clarify where we stand in the journey from bench to bedside.

The main goal of the Special Issue to explore the current approaches of interdisciplinary/multidisciplinary teams which include systems for the localized delivery of new therapies to joints and new scaffolds to support the growth and differentiation of stem cells into tissues such as bone, cartilage, and tendon. This Special Issue aims to promote ongoing research in the specific field connecting stem cells and materials, which is promising for next-generation treatment. Original research and review articles are welcome.

Potential topics include but are not limited to the following:

  • Advanced materials for MSK therapy (in vitro, in vivo)
  • Stem cells and biomaterials for MSK therapy (in vitro, in vivo)
  • Exosome/stem cells and biomaterials for MSK therapy (in vitro, in vivo)
  • Cellular physiology of stem cells and biomaterials in MSK therapy (in vitro, in vivo)
  • Cell-laden hydrogels for tissue engineering
  • 3D bio-printing of biomaterials combined with stem cells, and their importance in MSK therapy
  • Clinical studies related to MSK therapy with reference to materials and stem cells
Stem Cells International
 Journal metrics
See full report
Acceptance rate15%
Submission to final decision153 days
Acceptance to publication27 days
CiteScore8.500
Journal Citation Indicator0.800
Impact Factor4.3
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.